Eloxx Pharmaceuticals Inc (OTCQB:ELOX)

10.45
Delayed Data
As of 3:47pm ET
 -0.25 / -2.34%
Today’s Change
3.10
Today|||52-Week Range
10.75
+30.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization14.0K9.4K9.2K8.2K
 
 
 
 
 
 
Operating ExpensesGross Income-14.0K-9.4K-9.2K-8.2K
 
 
 
 
 
General Expenses493.5K332.5K663.8K619.2K
 
 
 
 
 
Other Operating Expenses0.000.00-140.0K0.00
 
 
Research And Development193.4K117.3K110.1K127.4K
 
 
 
 
 
Total Operating Expenses507.5K341.9K533.0K627.4K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-507.5K-341.9K-533.0K-627.4K
 
 
 
 
 
Extraordinary Credit319.5K55.6K--0.00
 
 
 
Extraordinary Charge-1.0M0.00-1.3M-512.1K
 
 
 
 
Interest Expense On Debt1.9K54.0K209.2K127.4K
 
 
 
 
 
Other Expenses0.00-1.7M22.4K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M-2.1M-2.0M-1.3M
 
 
 
 
 
Income Taxes-400.0K0.000.000.00
 
 
Preferred Dividend-15.8K-9.0K-363.6K-114.3K
 
 
 
 
 
Net Income-789.8K-2.1M-2.0M-1.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.0M1.2M1.5M2.1M
 
 
 
 
 
Shares To Calculate EPS Diluted1.0M1.2M1.5M2.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80-$1.80-$1.80-$0.60
 
 
 
 
 
EPS Diluted-$0.80-$1.80-$1.62-$0.60